- Home
- ACRS vs CHGG Comparison
ACRS vs CHGG Comparison
Compare ACRS & CHGG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACRS
- CHGG
- Stock Information
- Founded
- ACRS 2012
- CHGG 2005
- Country
- ACRS United States
- CHGG United States
- Employees
- ACRS N/A
- CHGG N/A
- Industry
- ACRS Biotechnology: Pharmaceutical Preparations
- CHGG Other Consumer Services
- Sector
- ACRS Health Care
- CHGG Real Estate
- Exchange
- ACRS Nasdaq
- CHGG Nasdaq
- Market Cap
- ACRS 165.7M
- CHGG 143.9M
- IPO Year
- ACRS 2015
- CHGG 2013
- Fundamental
- Price
- ACRS $1.93
- CHGG $1.66
- Analyst Decision
- ACRS Strong Buy
- CHGG Sell
- Analyst Count
- ACRS 9
- CHGG 7
- Target Price
- ACRS $9.25
- CHGG $1.70
- AVG Volume (30 Days)
- ACRS 800.9K
- CHGG 4.3M
- Earning Date
- ACRS 11-05-2025
- CHGG 11-11-2025
- Dividend Yield
- ACRS N/A
- CHGG N/A
- EPS Growth
- ACRS N/A
- CHGG N/A
- EPS
- ACRS N/A
- CHGG N/A
- Revenue
- ACRS $16,789,000.00
- CHGG $506,584,000.00
- Revenue This Year
- ACRS N/A
- CHGG N/A
- Revenue Next Year
- ACRS N/A
- CHGG N/A
- P/E Ratio
- ACRS N/A
- CHGG N/A
- Revenue Growth
- ACRS N/A
- CHGG N/A
- 52 Week Low
- ACRS $1.05
- CHGG $0.44
- 52 Week High
- ACRS $5.17
- CHGG $2.73
- Technical
- Relative Strength Index (RSI)
- ACRS 54.35
- CHGG 57.06
- Support Level
- ACRS $1.81
- CHGG $1.31
- Resistance Level
- ACRS $2.16
- CHGG $1.73
- Average True Range (ATR)
- ACRS 0.12
- CHGG 0.20
- MACD
- ACRS -0.03
- CHGG -0.00
- Stochastic Oscillator
- ACRS 34.29
- CHGG 63.83
About ACRS Aclaris Therapeutics Inc.
Aclaris Therapeutics Inc is a clinical-stage biopharmaceutical company that operates in the United States. It focuses on developing novel drug candidates for immuno-inflammatory diseases. The company operates in two reportable segments: therapeutics and contract research. The therapeutics segment is focused on identifying and developing inventive therapies to address unmet needs for immuno-inflammatory diseases, and the contract research segment is engaged in providing laboratory services. A majority of the company's revenue is derived from the therapeutics segment. The various drug candidates in its product pipeline are Zunsemetinib, which is an Oral MK2 Inhibitor; ATI-2138, an ITJ Inhibitor; Bosakitug, ATI-052, and Lepzacitinib.
About CHGG Chegg Inc.
Chegg Inc is an American educational services company. The Chegg platform provides products and services to support learners with their academic course materials, as well as their career and personal skills development. The company's service and product offerings fall into two categories: Subscription Services, which encompasses Chegg Study Pack, Chegg Study, Chegg Writing, Chegg Math, and Busuu offerings that can be accessed internationally through the company's websites and on mobile devices, and Skills and Other, which encompasses skills, advertising services, print textbooks, and eTextbooks offerings.